For: | Zhang B, Ding F, Chen T, Xia LH, Qian J, Lv GY. Ultrasound hepatic/renal ratio and hepatic attenuation rate for quantifying liver fat content. World J Gastroenterol 2014; 20(47): 17985-17992 [PMID: 25548498 DOI: 10.3748/wjg.v20.i47.17985] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i47/17985.htm |
Number | Citing Articles |
1 |
György Jermendy, Márton Kolossváry, Ibolya Dudás, Ádám L. Jermendy, Alexisz Panajotu, Imre F. Suhai, Zsófia D. Drobni, Júlia Karády, Ádám D. Tárnoki, Dávid L. Tárnoki, Szilard Voros, Béla Merkely, Pál Maurovich-Horvat. Effect of genetic and environmental influences on hepatic steatosis: A classical twin study based on computed tomography. Imaging 2020; 12(1): 15 doi: 10.1556/1647.2020.00006
|
2 |
Wei Li, Yan Wang, Feng He, Zhuo Liu, Jie Dong, Yuqi Zhang, Tianfang Li, Shengyun Liu, En Chen. Association between triglyceride–glucose index and nonalcoholic fatty liver disease in type 2 diabetes mellitus. BMC Endocrine Disorders 2022; 22(1) doi: 10.1186/s12902-022-01172-7
|
3 |
Boris Joutovsky, Alexander Ortiz, Camille Bentley, Jing Gao. Portable Ultrasonography to Assess Adult Hepatosteatosis in Rural Ecuador. Journal of Osteopathic Medicine 2020; 120(9): 553 doi: 10.7556/jaoa.2020.095
|
4 |
Çağrı Damar, Emregül Işık, Şükrü Güngör. Relationship between Quantitative Sonographic Measurements and Serum Biochemical Parameters in Childhood Obesity. Pediatric Gastroenterology, Hepatology & Nutrition 2021; 24(5): 470 doi: 10.5223/pghn.2021.24.5.470
|
5 |
J.-P. Kühn, M.C. Spoerl, C. Mahlke, K. Hegenscheid. Techniken zur Leberfettquantifizierung bei der Risikostratifikation von Diabetikern. Der Radiologe 2015; 55(4): 308 doi: 10.1007/s00117-014-2720-9
|
6 |
Laura De Rosa, Antonio Salvati, Ferruccio Bonino, Maurizia Rossana Brunetto, Francesco Faita. Effects of Different Scan Projections on the Quantitative Ultrasound-Based Evaluation of Hepatic Steatosis. Healthcare 2022; 10(2): 374 doi: 10.3390/healthcare10020374
|
7 |
Jiang-Hua Zhou, Jing-Jing Cai, Zhi-Gang She, Hong-Liang Li. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. World Journal of Gastroenterology 2019; 25(11): 1307-1326 doi: 10.3748/wjg.v25.i11.1307
|
8 |
T. Hydes, E. Brown, A. Hamid, A.C. Bateman, D.J. Cuthbertson. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications. Clinical Therapeutics 2021; 43(9): 1505 doi: 10.1016/j.clinthera.2021.07.012
|
9 |
Masato Yoneda, Yasushi Honda, Asako Nogami, Kento Imajo, Atsushi Nakajima. Advances in ultrasound elastography for nonalcoholic fatty liver disease. Journal of Medical Ultrasonics 2020; 47(4): 521 doi: 10.1007/s10396-020-01040-8
|
10 |
Amit Das, Mary Connell, Shailesh Khetarpal. Digital image analysis of ultrasound images using machine learning to diagnose pediatric nonalcoholic fatty liver disease. Clinical Imaging 2021; 77: 62 doi: 10.1016/j.clinimag.2021.02.038
|
11 |
Haofei Hu, Yong Han, Changchun Cao, Yongcheng He. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03611-4
|
12 |
Jérémy Dana, Aïna Venkatasamy, Antonio Saviano, Joachim Lupberger, Yujin Hoshida, Valérie Vilgrain, Pierre Nahon, Caroline Reinhold, Benoit Gallix, Thomas F. Baumert. Conventional and artificial intelligence-based imaging for biomarker discovery in chronic liver disease. Hepatology International 2022; 16(3): 509 doi: 10.1007/s12072-022-10303-0
|
13 |
A. L. Alyavi, G. N. Sobirova, A. O. Abdullaev, D. A. Shadmanova. Ways to overcome difficulties in diagnosing non-alcoholic fatty liver disease. Experimental and Clinical Gastroenterology 2024; (10): 175 doi: 10.31146/1682-8658-ecg-218-10-175-181
|
14 |
Anna Egresi, Gabriella Lengyel, Krisztina Hagymási. Non-invasive assessment of fatty liver. Orvosi Hetilap 2015; 156(14): 543 doi: 10.1556/OH.2015.30123
|
15 |
Haofei Hu, Changchun Cao, Yong Han, Yongcheng He. Triglyceride affects the association between estimated glomerular filtration rate and the onset of non-alcoholic fatty liver disease: A second analysis of a Chinese cohort study. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.984241
|
16 |
Ioan Sporea, Roxana Șirli, Alina Popescu. Ultrasound Elastography. 2020; doi: 10.5772/intechopen.87938
|
17 |
Kolar Venkataravanappa Vineetha, Sorikunte Huchappa Anand, Kambathnahalli Paramashivaiah Suresh Babu. PREVALENCE OF FATTY LIVER AND ITS ASSOCIATION WITH HIGH TOTAL CHOLESTEROL IN PEOPLE OF TUMKUR, INDIA. Journal of Evolution of Medical and Dental Sciences 2017; 6(16): 1264 doi: 10.14260/Jemds/2017/275
|
18 |
Melike Elif Kalfaoglu. Evaluation of Hepatic/Renal and Splenic/Renal Echointensity Ratio Using Ultrasonography in Diabetic Nephropathy. Diagnostics 2023; 13(14): 2401 doi: 10.3390/diagnostics13142401
|
19 |
Rui Li, Yang Bu, Chendong Yang, Jizeng Wang. Effects of Lipid Deposition on Viscoelastic Response in Human Hepatic Cell Line HepG2. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.684121
|
20 |
Shrivuthsun Srigandan, Marilyn Zelesco, Steven Abbott, Christopher J Welman. Correlation between hepatorenal index and attenuation imaging for assessing hepatic steatosis. Australasian Journal of Ultrasound in Medicine 2022; 25(3): 107 doi: 10.1002/ajum.12297
|
21 |
Jiang Li, Xiaolin Zhang, Jinying Tian, Juan Li, Xuechen Li, Song Wu, Yuying Liu, Jingyan Han, Fei Ye. CX08005, a Protein Tyrosine Phosphatase 1B Inhibitor, Attenuated Hepatic Lipid Accumulation and Microcirculation Dysfunction Associated with Nonalcoholic Fatty Liver Disease. Pharmaceuticals 2023; 16(1): 106 doi: 10.3390/ph16010106
|
22 |
Kai Sun, Alan Hodges, Maen Abdelrahim. Liver Cancer - Genesis, Progression and Metastasis. 2023; doi: 10.5772/intechopen.106816
|
23 |
Pingping Wang, Danlei Song, JiaHao Han, Jing Zhang, Huihui Chen, Ruixia Gao, Huiming Shen, Jia Li. Comparing Three Ultrasound-Based Techniques for Diagnosing and Grading Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease. Academic Radiology 2024; doi: 10.1016/j.acra.2024.09.002
|
24 |
Christoph F. Dietrich, Long Shi, Axel Löwe, Yi Dong, Andrej Potthoff, Zeno Sparchez, Andreas Teufel, Sabine Guth, Jonas Koch, Richard G Barr, Xin-Wu Cui. Conventional ultrasound for diagnosis of hepatic steatosis is better than believed. Zeitschrift für Gastroenterologie 2022; 60(08): 1235 doi: 10.1055/a-1491-1771
|
25 |
Hsun-Chin Chao, Hsin-Yeh Lin. Comparison of Body Mass Index and Fat Indices in Predicting the Severity of Nonalcoholic Fatty Liver Disease Among Children Who Are Overweight and Obese. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.724426
|
26 |
Javier Ampuero. General Overview About the Current Management of Nonalcoholic Fatty Liver Disease. Clinical Drug Investigation 2022; 42(S1): 39 doi: 10.1007/s40261-022-01142-w
|
27 |
Masato YONEDA, Yasushi HONDA, Asako NOGAMI, Kento IMAJO, Atsushi NAKAJIMA. Advances in ultrasound elastography for nonalcoholic fatty liver disease. Choonpa Igaku 2022; 49(5): 397 doi: 10.3179/jjmu.JJMU.R.202
|
28 |
K.C. van Son, L.C. te Nijenhuis-Noort, S.C. Boone, D.O. Mook-Kanamori, A.G. Holleboom, P.R. Roos, H.J. Lamb, G. Alblas, M.J. Coenraad, F.R. Rosendaal, R. de Mutsert, M.E. Tushuizen. Prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in a middle-aged population with overweight and normal liver enzymes, and diagnostic accuracy of noninvasive proxies. Medicine 2024; 103(1): e34934 doi: 10.1097/MD.0000000000034934
|
29 |
Masashi Hirooka, Yohei Koizumi, Teruki Miyake, Takao Watanabe, Osamu Yoshida, Yoshio Tokumoto, Atsushi Yukimoto, Yoshiko Nakamura, Yusuke Imai, Masanori Abe, Yoichi Hiasa. Nonalcoholic fatty liver with a hepatic arterial buffer response strongly associated with future metabolic disease. Hepatology Communications 2017; 1(7): 623 doi: 10.1002/hep4.1070
|
30 |
Stefano Ballestri, Fabio Nascimbeni, Simonetta Lugari, Amedeo Lonardo, Giampiero Francica. A critical appraisal of the use of ultrasound in hepatic steatosis. Expert Review of Gastroenterology & Hepatology 2019; 13(7): 667 doi: 10.1080/17474124.2019.1621164
|